Status:
TERMINATED
A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
50+ years
Brief Summary
The purpose of this study was to assess the pigmentation in the trabecular meshwork of patients who had been treated for at least 2 years with TRAVATAN compared with patients without exposure (or less...
Eligibility Criteria
Inclusion
- Diagnosis of open-angle glaucoma without pseudoexfoliation or pigment dispersion component;
- Either two or more years of dosing with Travatan, or no prior exposure (less than 1 month) to a topical ocular prostaglandin;
- Requires a trabeculectomy;
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Pseudoexfoliation or pigment dispersion;
- History of chronic or recurrent severe inflammatory eye disease;
- History of or current ocular infection or ocular inflammation within the past 3 months in either eye;
- Greater than one month but less than two years of exposure to TRAVATAN;
- Pregnant, breast-feeding, not using highly effective birth control;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT01485822
Start Date
July 1 2004
End Date
February 1 2012
Last Update
May 14 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.